# Indutrade Q3 2026 Earnings Highlights

> Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026.
- Title: Indutrade Q3 2026 Earnings Highlights · Seekingalpha
- Summary: Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026. Indutrade AB achieved 13% net sales growth and 6% organic expansion in Q3…
- Keywords: indutrade ab, q3 2026, earnings call, net sales, organic growth, medtech, pharma, acquisitions, money, business, Indutrade, 2026
- Source: Seekingalpha — https://seekingalpha.com/article/4956955-indutrade-ab-publ-iddwf-q3-2026-earnings-call-transcript
- Author: SA Transcripts
- Published: 2026-10-23T14:27:39+00:00
- Read time: 1 min
- Topics: indutrade ab, q3 2026, earnings call, net sales, organic growth, medtech, pharma, acquisitions, money, business
## Q3 2026 Results
Indutrade AB reported 13% net sales growth and 6% organic expansion in Q3 2026.
## Strong Demand in MedTech and Pharma
Demand improved for companies with customers in MedTech and Pharma, driving 6% organic growth.
## Acquisitions and Cash Flow
13 acquisitions announced this year with EBITA margin rising from 14.6% to 15.3% and cash flow up 20%.
## Key takeaway

Indutrade AB achieved 13% net sales growth and 6% organic expansion in Q3 2026 with strong MedTech and Pharma demand.